SYK · Stryker Corporation

Healthcare NYQ United States stryker.com ↗
Val Gro Qua Mom Sta Cap P/S4.09 P/E Fwd P/E16.46 PEG1.17 52W –  RSI Target$376.28 (+36.6%) Beta0.77 Div1.29%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Devices Portage, United States 56,000 employees
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 27 Overbought · 100
Signal Oversold
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
4Bearish
0Neutral

Key Signals 3

▲ Double Bottom Major reversal 2026-06-25 · $314.63
Two lows ~$294.29 — bullish reversal confirmed
Learn more →
▲ Double Bottom Major reversal 2026-07-27 · $333.86
Two lows ~$302.94 — bullish reversal confirmed
Learn more →
▼ Double Top Major reversal 2026-09-01 · $317.62
Two peaks ~$351.13 — bearish reversal confirmed
Learn more →

Momentum Signals 7

▲ MACD Bullish Crossover 2026-05-14 · $304.7
▲ MACD Bullish Crossover 2026-06-05 · $304.85
▲ MACD Bullish Crossover 2026-07-27 · $336.74
▲ Bull Flag 2026-08-10 · $343.87

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Oct 29, 2026
Beat Rate 88%
Consensus BUY
Analyst Upside +36.6%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
88% 7/8 quarters
Wall Street Consensus
BUY
22
6
BuyHoldSell
Price Target Range
$376.28 +36.6% upside
Low $315 High $465
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 65.59%Last 12 Months
Operating Margin 27.02%Last 12 Months
Return on Equity 16.51%Last 12 Months
Revenue Growth 9.40%Year over Year
Free Cash Flow 4.11BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 64.39Most Recent Quarter
Current Ratio 2.16Most Recent Quarter
Cash 3.48BMost Recent Quarter
Total Debt 15.45BMost Recent Quarter
Net Debt Most Recent Quarter
How SYK Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap105.70B
Enterprise Value117.67B
Trailing P/E28.00
Forward P/E16.46
PEG Ratio (5yr)1.17
Price/Sales (ttm)4.09
Price/Book (mrq)4.41
EV/Revenue4.55
EV/EBITDA15.95
Share Statistics
Avg Vol (3m)2.59M
Shares Outstanding383.57M
Float348.14M
% Held by Insiders5.36%
% Held by Institutions82.84%
Short Ratio3.27
Short % of Float2.08%
Profitability
Gross Margin65.59%
Operating Margin (ttm)27.02%
Profit Margin14.43%
Return on Assets (ttm)8.16%
Return on Equity (ttm)16.51%
Income Statement
Revenue (ttm)25.84B
Revenue Growth (yoy)9.40%
Gross Profit (ttm)16.95B
EBITDA7.38B
Net Income (ttm)3.73B
Diluted EPS (ttm)9.84
EPS Growth (yoy)44.10%
Balance Sheet
Total Cash (mrq)3.48B
Total Debt (mrq)15.45B
Debt / Equity (mrq)64.39
Current Ratio (mrq)2.16
Book Value / Share62.54
Operating CF (ttm)5.53B
Free Cash Flow (ttm)4.11B
Trading & Dividends
Beta (5Y)0.77
50-Day MA325.78
200-Day MA337.14
Fwd Dividend Yield1.30%
Payout Ratio36.06%
Income
Dividend Yield 1.29%Last 12 Months
Annual Rate 3.52Forward
Payout Ratio 36.06%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 36.06%
Monthly Dividends
Ownership Breakdown
Institutional 82.84% Insider 5.36% Public 11.8%
Short Interest 2.08% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in SYK in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value